Where does Jeisys Medical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Jeisys Medical Inc. ranks #15,392 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Jeisys Medical Inc. hold?

Jeisys Medical Inc. holds 19 US utility patents granted between 2021 and 2025, spanning 6 technology areas.

What is Jeisys Medical Inc.'s Innovation Score?

Jeisys Medical Inc. has an Innovation Score of 45.7 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Jeisys Medical Inc. focus on?

Jeisys Medical Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 16 patents, ranking #233 of 1,943 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Jeisys Medical Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Jeisys Medical Inc..

What does claim depth mean for Jeisys Medical Inc.'s patents?

Jeisys Medical Inc.'s patents average 11.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Jeisys Medical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jeisys Medical Inc.

USPTO PatentsView assignee record - 19 granted patents across 6 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jeisys ranks #15,392 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 6 technology areas.

#15,392
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.7/100): 11.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15392 · Foreign Corporation #15,392 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 19 grants
MID-PACK #15,392/49,997
PHOTO-FINISH Japan Cooperation…
CPC-NARROW A61N · 6 areas
INNOV-PAR 45.7/100
CLAIMS-PAR 11.2 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Japan Cooperation Center Petroleum (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Jeisys’s 45.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (23%) Velocity 20.0 pts (44%) Breadth 8.7 pts (19%) Claim depth 6.7 pts (15%)

Qualcomm Incorporated · highest

85
Jeisys Medical · this assignee

46
3D Lighting… · lowest

7

What this shows Jeisys's Innovation Score is 45.7/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Jeisys?

Each dot is one of Jeisys’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Jeisys’s own 11.2 claims/patent is ABOVE the 7.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Jeisys vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Jeisys's grants concentrate

Jeisys Medical Inc. is a focused PatentsView assignee: 6 CPC subclasses with 84.2% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (7 grants) versus a trough of 2 in 2021. By volume, Jeisys sits between Jetool Corp. and Joint Development, Inc..

Jeisys's three-year grant acceleration

Jeisys Medical Inc. shows 14 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Jetool

19
JF Microtechnolog…

19
Joinset

19
Japan Cooperation…

19
Jenkem Technology…

19
Jiashan Sansi Opt…

19
Johnan Manufactur…

19
Joint Development

19
Jeisys Medical ◀

19

What this shows Jeisys holds 19 patents at rank #15,394, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jeisys

By rank, the assignees closest to #15,394 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Jeisys's primary technology class.

Jeisys's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Jeisys Medical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	10.5%
2022	4	21.1%
2023	3	15.8%
2024	7	36.8%
2025partial year	3	15.8%

Which technologies does Jeisys Medical Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 16

A61B - DIAGNOSIS; SURGERY; Identification 11

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 2

B06B - Methods OR Apparatus FOR Generating OR Transmitting Mechanical Vibrations OF Infrasonic, Sonic, OR Ultrasonic Frequency, ; e.g.; FOR Performing Mechanical Work IN General 1

F16H - Gearing 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Jeisys Medical Inc.'s patent record in context - here's where to go next.

Jeisys Medical Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 84.2% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #15,392 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Jeisys Medical Inc. against Jetool Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.